They came, they partnered, they set up joint ventures - and then they left.
Among the world's major generics firms, very few are now operating in China, and the sector is littered with failed...
Can An Elephant Crack China’s Bamboo Ceiling For Generics?
Among the many challenges facing foreign generics firms operating in China, dealing with ever-tightening policies and regulations is probably the toughest, and has already forced several multinationals to quit the market. But one Indian joint venture is looking to effectively exploit targeted niche opportunities.
